Who makes MMI combined with IID?

MMI combined with IID is developed by Xiao-Ming Mao.

What development phase is MMI combined with IID in?

MMI combined with IID is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

MMI combined with IID

Xiao-Ming Mao · FDA-approved active Small molecule Quality 1/100

At a glance

Generic name	MMI combined with IID
Also known as	methimazole,tapazole;dexamethasone,hexadecadrol
Sponsor	Xiao-Ming Mao
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Prevention Relapse of Graves' Disease by Intrathyroid Injection of Dexamethasone (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

MMI combined with IID CI brief — competitive landscape report
MMI combined with IID updates RSS · CI watch RSS
Xiao-Ming Mao portfolio CI